Actionable news
0
All posts from Actionable news
Actionable news in ADAP: Adaptimmune Therapeutics PLC,

Adaptimmune Therapeutics PLC ADR

Average Recommendation: Overweight Average Target Price: 18.33
Number of Ratings: 3 Current Quarters Estimate: -0.28
FY Report Date: 12 / 2016 Current Year's Estimate: -0.79
Last Quarter's Earnings: N/A Median PE on CY...

More